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ABSTRACT: We evaluate ﬁne particulate matter (PM2.5) exposure−
response models to propose a consistent set of global eﬀect factors for
product and policy assessments across spatial scales and across urban
and rural environments. Relationships among exposure concen-
trations and PM2.5-attributable health eﬀects largely depend on
location, population density, and mortality rates. Existing eﬀect factors
build mostly on an essentially linear exposure−response function with
coeﬃcients from the American Cancer Society study. In contrast, the
Global Burden of Disease analysis oﬀers a nonlinear integrated
exposure−response (IER) model with coeﬃcients derived from
numerous epidemiological studies covering a wide range of exposure
concentrations. We explore the IER, additionally provide a simpliﬁed
regression as a function of PM2.5 level, mortality rates, and severity,
and compare results with eﬀect factors derived from the recently
published global exposure mortality model (GEMM). Uncertainty in eﬀect factors is dominated by the exposure−response
shape, background mortality, and geographic variability. Our central IER-based eﬀect factor estimates for diﬀerent regions do
not diﬀer substantially from previous estimates. However, IER estimates exhibit signiﬁcant variability between locations as well
as between urban and rural environments, driven primarily by variability in PM2.5 concentrations and mortality rates. Using the
IER as the basis for eﬀect factors presents a consistent picture of global PM2.5-related eﬀects for use in product and policy
assessment frameworks.
1. INTRODUCTION
1.1. History of Epidemiology-Based Eﬀect Factors.
We evaluate ﬁne particulate matter (PM2.5) exposure−
response models to propose a consistent set of global eﬀect
factors across spatial scales and across urban and rural
environments for use in product and policy assessments,
such as life cycle impact assessment (LCIA) and health impact
assessment (HIA). Exposure to PM2.5 is the leading environ-
mental contributor to human disease burden, with more than
seven million deaths globally attributed to ambient and
household PM2.5 exposure in 2015.
1 The inﬂuence of exposure
to PM2.5 on mortality rates became clear with the “Harvard Six
Cities” study in 1993.2 The eﬀect seen was so large that a
second, larger, study was conducted involving more than
500 000 subjects from 151 communities within the United
States. This American Cancer Society (ACS) study,3 published
in 1995, conﬁrmed the relationship between exposure to PM2.5
and mortality rates for concentrations and composition of
PM2.5 in the United States with an eﬀect size roughly one-third
as large as that found in the Six Cities study.
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At about the same time, Hofstetter4 began working on
methods for comparing environmental impacts from pollutant
emissions along product and service life cycles. As part of this
eﬀort, he developed the ﬁrst approach to address exposure to
PM2.5 in large-scale emission-based comparisons. In such
comparisons, the most common measure of the relationship
between population exposure and health eﬀects is the “eﬀect
factor”, typically expressed in terms of years of life lost (YLL)
or disability-adjusted life years (DALY) for a given population
per kilogram intake (e.g., via inhalation) of a pollutant. To be
suitable for evaluating diﬀerent emission situations, such eﬀect
factors are combined with human intake fractions relating
PM2.5 emissions to population intake.
5−7 Hofstetter4 applied
for his eﬀect factor estimates the PM2.5 risk coeﬃcient from the
ACS study (0.4% increase in mortality among adults [≥30
years of age] per μg/m3) to cardiopulmonary mortality rates
for European adults of 1400 deaths per 100 000 person-years.
He assumed that the entire eﬀect seen in the ACS study was
due to PM2.5 exposure and used a severity factor of 6.6 YLL/
death, deriving eﬀect factors for Europe of 41 YLL per kg
PM2.5 or sulfate inhaled.
Over the past 25 years, the Six Cities and ACS studies have
been frequently extended and reanalyzed,8−11 and several new
cohorts have been evaluated.12−20 These studies have
repeatedly conﬁrmed that mortality rates are higher at higher
levels of PM2.5 exposureeven after accounting (at the
individual level) for diﬀerences in behavior, socioeconomic
status, and other factors known to aﬀect mortality rates. A
recent meta-analysis of these studies associated a 1.1% increase
in cardiovascular mortality per μg/m3 increase in PM2.5, with
study-to-study results variability thought to be attributable to
diﬀerence in particle composition, building air exchange rates,
demographic factors, and meteorology.21
In parallel, several research groups have published new PM-
related eﬀect factors, including estimates yielding 58 YLL per
kg PM10 inhaled in Europe
22 and 64 YLL (78 DALY) per kg
PM2.5 inhaled in the United States.
23 More recent estimates are
more variable and in part substantially larger than previous
estimates,24,25 with estimates for example ranging for Europe
from 192 YLL (France) to 622 YLL (Bulgaria) per kg PM2.5
inhaled and for North America from 151 YLL (Mexico) to 395
YLL (Canada), with the United States at 287 YLL, per kg
PM2.5 inhaled.
24
All described estimates have relied on risk coeﬃcients from
the original ACS study or one of its follow-up studies. Van
Zelm et al. (2008)22 used a risk coeﬃcient of 0.43% (0.26−
0.91%) per μg/m3 PM10 based on Künzli’s synthesis of results
from the Six Cities and ACS studies.26 We note that because
the ACS study is much larger than the Six Cities study, Künzli’s
pooled risk coeﬃcient is very similar to the coeﬃcient from the
ACS study. Further, although the original coeﬃcients were
applied to PM2.5, in an attempt to be conservative, Künzli et
al.26 presented these as if they applied to all inhalable particles
(PM10). Gronlund et al.
23 used risk coeﬃcients of 0.6% (0.2−
1%) and 0.8% (0.1−1.6%) per μg/m3 PM2.5 for, respectively,
cardiopulmonary mortality and lung cancer, taken from the
2002 extension of the ACS study.8 These were applied to
disease-speciﬁc background mortality rates in the United States
in 1982−88 (640 deaths per 100 000 persons and year for
cardiopulmonary disease and 82 deaths per 100 000 persons
and year for lung cancer) combined with severity factors of 13
YLL (17 DALY) per death for cardiopulmonary disease and 27
YLL (28 DALY) per death for lung cancer. Recent studies24,25
used 1.3% (1.0−1.6%) and 1.4% (0.6−2.3%) per μg/m3 PM2.5
for, respectively, cardiopulmonary mortality and lung cancer
from the 2009 reanalysis of the ACS study, adjusted for
ecological covariates.9 The underlying risk coeﬃcients are
approximately three times larger than those used to support
Hofstetter’s original estimate of 41 YLL/kg PM2.5 inhaled.
4
These studies have attempted to characterize the uncertainty
inherent in their results by relying on estimates of the
parameter uncertainty in risk coeﬃcients from the underlying
epidemiological studies. None of these analyses, however,
considered the epistemic uncertainty introduced by using a
study conducted in the United States to estimate health
impacts from exposure to PM2.5 in other regions.
25
The original ACS study cohort was exposed to annual
average PM2.5 concentrations varying from 9 to 34 μg/m
3,3
while worldwide PM2.5 levels vary from <5 to >300 μg/m
3.27 If
the true relationship between PM2.5 concentration and
mortality is strictly proportional, risk estimates derived using
a proportional exposure−response model would be appro-
priate. However, if the true exposure−response relationship is
nonlinear, this approach (i.e., extrapolating globally from U.S.
results) is not satisfactory. Furthermore, the ACS study cohort
was exposed to PM2.5 with a composition resulting from a
speciﬁc source mixture and atmospheric conditions in the
United States, while worldwide PM2.5 compositions may diﬀer
signiﬁcantly from those in the United States.28 However, while
assessing and comparing emission scenarios aims at evaluating
all possible source types, consistently diﬀerentiating various
anthropogenic and nonanthropogenic PM2.5 sources would
require globally spatialized data that are currently lacking.
Finally, the ACS study cohort includes residents with an ethnic
mix, health-relevant behaviors (e.g., smoking, diet), socio-
economic status, and access to health care all speciﬁc to the
United States. However, if the inﬂuence of these coexposures
or behavioral factors is not multiplicative, then the use of an
exposure−response model based on relative risk does not
provide a satisfactory approach for decomposing observed
mortality into components attributable to exposure to ambient
PM2.5 and components attributable to other causal factors.
These issues of synthesizing evidence, shape of exposure−
response, potential diﬀerential toxicity, and extrapolation of
epidemiological results from the United States and Western
Europe to the rest of the world are relevant to various
assessment communities but also to regulatory authorities
around the world. All of them face the question of how best to
synthesize and interpret this large and growing body of
evidence on the mortality eﬀects from PM exposure. One
synthesis eﬀort of particular interest underlies the Global
Burden of Disease (GBD) studies. Since 2010, the GBD has
relied on an integrated exposure−response (IER) model to
characterize risks from exposure to PM2.5.
1,29−31 In this eﬀort,
(i) a variety of exposure−response functions was explored
instead of assuming proportionality, (ii) a counterfactual level
of pollution was explicitly accounted for, below which no eﬀect
would be seen, (iii) evidence from all major cohort studies of
ambient PM2.5 and mortality was synthesized, and (iv) it was
assumed that all ﬁne particles were equivalently toxic (per unit
mass inhaled), incorporating evidence from studies involving
exposure to active and passive cigarette smoke and indoor
smoke from cooking and heating using dung and other dirty
fuels.32,33 The IER approach has been well received and
provided the basis for a number of prominent estimates of the
global health impact of exposure to PM2.5.
29,34−36
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1.2. Toward Appropriate Global Eﬀect Factor
Estimates. At the 2016 Pellston expert workshop on 'Global
Guidance for Life Cycle Impact Assessment Indicators and
Methods',37,38 an international group of researchers focused on
understanding the suitability of the IER approach for
developing globally applicable PM2.5 eﬀect factors linking
change in mortality to change in exposure. The main goal was
to provide PM2.5 eﬀect factors appropriate for diﬀerent
emission situations (unknown location, known continent or
subcontinent, known country or subnational region, and urban
area emissions with known city). For each situation, we apply
the IER from the 2015 GBD study to (i) understand the
factors responsible for variation in derived eﬀect factors, (ii)
compare these results with previous estimates and with
estimates derived using an alternative exposure−response
model, and (iii) promote discussion of the importance of
approaches for synthesizing evidence and characterizing eﬀect
factor uncertainty. Combining our eﬀect factors with intake
fractions will allow for a spatialized evaluation of diﬀerent
PM2.5 emission situations suitable for use in LCIA, HIA, other
comparative risk and impact assessments, and analyses of
emission reduction policies.
2. MATERIALS AND METHODS
2.1. General Approach Followed. Our approach for
deriving eﬀect factors for exposure to PM2.5 involves the
following steps. (1) Synthesis of epidemiological literature is
used to provide a risk coeﬃcient, β (% increase in mortality
rate per μg PM2.5/m
3), or a set of d disease-speciﬁc (and, for
certain diseases, age-speciﬁc) risk coeﬃcients, βd1, βd2, ..., βdn,
reﬂecting the selected synthesis of exposure−response
functions of some arbitrary shape. (2) Estimates of the annual
mean PM2.5 exposure concentrations (μg/m
3) and data on
overall mortality, M (deaths/year), in the regions of interest
are obtained. (3) Exposure estimates are combined with
mortality rates to compute, in each region of interest, the
relative risk, RR (dimensionless), corresponding to the
ambient PM2.5 exposure concentration level, C (μg/m
3), the
attributable risk fraction, ARF (dimensionless), as the fraction
of mortality attributable to exposure to PM2.5, and the related
PM2.5-attributable mortality, MPM2.5 (deaths/year). (4) Esti-
mates of severity, SF (YLL/death or DALY/death), appro-
priate for each cause of death or disability and region of
interest are obtained. (5) The above factors are used to
compute the health eﬀects (YLL or DALY) from exposure to
PM2.5 in each region of interest as exposure−response factor,
ERF = dMPM2.5/dC × SF. (6) To link health burden to human
intake, the change in intake is computed as the product of the
change in annual PM2.5 concentration, ΔC (μg/m3), a nominal
breathing rate, BR (m3/person/d), and the population count in
each region of interest, Npop (persons). After converting
micrograms to kilograms and days to year, we yield a dose−
r e s p o n s e f a c t o r ,
= × × ×μ( )DRF ERF N BR/ 10 365pop 9 gkg dyear . (7) Eﬀect
factors, EF (YLL or DALY per kg PM2.5 inhaled), are ﬁnally
calculated and deﬁned as the slope of the relationship between
eﬀects and inhalation exposure. This process provides
additional health burden attributable to PM2.5 exposure,
ΔMPM2.5 (deaths/year), per increment of increased intake of
PM2.5, ΔI (kg inhaled/year), by the exposed population in
each region of interest.
Following this approach, our analysis relies on the IER
model from the 2015 GBD study and uses data for PM2.5
exposure concentration, mortality, severity, population count,
and breathing rates as detailed in the following.
2.2. Synthesis of Epidemiological Evidence. There
have been several attempts to synthesize evidence from existing
epidemiological studies but none as ambitious as the GBD’s
IER. On the assumption of the equitoxicity of PM2.5 (i.e.,
assuming particles are equivalently toxic per unit mass
inhaled),1 the IER considers evidence not only from
epidemiological studies of ambient PM2.5 but also from
epidemiological studies examining the impact of exposure to
indoor smoke and from exposure to both active and passive
cigarette smoke.32,33 The general form of the GBD’s IER
relative risk (RR) models is:
α= + × − ≥
<
β− × − δl
m
ooo
n
ooo
RR C
C C
C C
( )
1 (1 e ) for
1 for
C C( )
0
0
0
(1)
with C being the PM2.5 exposure concentration, C0 the
theoretical minimum risk exposure level (TMREL; also
referred to as “counterfactual”), 1 + α the maximum relative
risk, β the ratio of relative risk at low-to-high PM2.5 exposure,
and δ the power of PM2.5 exposure concentration.
The 2010 GBD study was the ﬁrst major application of the
IER model.29 This model is well known, has been widely used,
and has been reﬁtted twice, incorporating additional
epidemiological studies and using somewhat diﬀerent statistical
methods. The 2013 coeﬃcients32 have been used exten-
sively.34,35 The most recent update produced the 2015
coeﬃcients that provided the basis for a study reviewing 25
years of mortality attributable to PM2.5 exposure.
36 The IER
model is applied separately to each of ﬁve causes of death:
ischemic heart disease (IHD), stroke, chronic obstructive
pulmonary disease (COPD), and lung cancer in adults, as well
as acute lower respiratory infections (ALRI) in children. For
IHD and stroke, the IER model is applied separately to each of
12 age groups: 25−29 years, ..., 75−79 years, and ≥80 years.
For COPD and lung cancer, IER model parameters are
estimated only once and they apply to all individuals over 25
years of age. For ALRI, the model is applied to children below
5 years of age.
The IER model used in the GBD study32 accounts for
uncertainty by providing 1000 equally likely sets of values for
the model coeﬃcients α, β, δ, and C0 for each disease and age
group of interest. These sets of coeﬃcients are generated by
creating 1000 equally likely data sets and then determining the
values of α, β, δ, and C0, with a mean C0 = 4.2 μg/m
3.
Individual data sets are generated by drawing one set of values
of relative risk and PM2.5 exposure concentration for each
cohort study under consideration from a pool of relative risk
and PM2.5 exposure concentration values thought to represent
the study.
Strengths of the GBD’s IER model include the following:36
(i) It reﬂects virtually all available published cohort studies of
mortality attributable to PM2.5 exposure. (ii) It begins with a
highly ﬂexible set of exposure−response functions and
objective criteria to select among them. (iii) It uses
sophisticated statistical methods to account for between-
study heterogeneity. (iv) It provides users with an approach for
characterizing parameter uncertainty. (v) It includes input
from a large group of leading experts in the ﬁeld of PM2.5
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epidemiology. (vi) It is published in the peer-reviewed
literature, widely used, and updated frequently. (vii) It covers
the entire range of PM2.5 exposure concentrations of interest
by incorporating evidence from studies of ambient PM2.5,
indoor PM2.5 from cook stoves and passive smoking, along
with data on PM2.5 exposures and risks among active smokers.
Potential limitations of the GBD’s IER model include the
following: (i) The eﬀect of including epidemiological evidence
from studies of direct smoking is to ﬂatten the exposure−
response function at high concentrations, which is especially
relevant for populations exposed to highly polluted ambient air
(e.g., urban China, India). (ii) A secondary eﬀect of including
evidence from direct smoking is that reported uncertainty in
estimates of the slope decreases as the concentration increases,
with the result that for regions with highly polluted ambient air
the IER suggests that the slope is known quite precisely,
whereas in fact there is the least direct evidence. (iii) The IER
model provides no information about model uncertainty
introduced by fundamental lack of scientiﬁc understanding of
issues necessary to interpret the results as causal or to apply
risk estimates to populations that have not been studied
epidemiologically or which are exposed to PM with diﬀerent
composition or particle size than those seen in the considered
epidemiological studies. (iv) The validity of the IER model,
hence, depends on two strong assumptions. The ﬁrst
assumption is that PM2.5 toxicity does not depend on source
or chemical composition, since despite substantial eﬀorts
neither epidemiological nor toxicological research has con-
clusively identiﬁed particular sources or components that
uniquely determine the toxicity of PM2.5.
36 When used to
evaluate emissions, the second assumption is that the exposure
concentration needed for the IER model can be obtained from
the total inhaled PM2.5 mass per unit emission provided by the
intake fraction.
2.3. Model Input Data. 2.3.1. Spatial Resolution of the
Analysis. Our analysis considers 175 countries, 18 of which
were further divided into subnational regions. The United
States was divided into 51 regions (50 states and American
Samoa). India was divided into 64 regions (32 urban and 32
rural). China was divided into its 34 provinces, Mexico into 32
states, Brazil into 26 states, Saudi Arabia into 13 provinces, and
the UK into 13 counties. In addition, several countries
(including Australia, Canada, Gabon, Indonesia, Kenya,
Norway, Somalia, Spain, and Uganda) were divided into two
and Russia into three regions located in diﬀerent subcon-
tinents. This yields 419 regions studied.39,40 When aggregating
regional and national results to the level of 8 continents and 16
subcontinents, we grouped Africa and the Middle East as one
continent, Latin America and the Caribbean as one continent,
and identify the northern regions of North America, Europe,
and Central Asia as a distinct continental region.40 In addition,
we considered 3448 cities (i.e., urbanized areas with more than
100 000 inhabitants).41 Following these spatial resolutions
renders our resulting eﬀect factors consistent with related
intake fraction estimates.39
2.3.2. Fine Particulate Matter Exposure Levels. We
obtained consistent estimates of the 2016 annual average
concentrations of PM2.5 prevalent in each of the 419 regions
and 3448 cities considered in our analysis from the World
Health Organization.27,42 PM2.5 exposure levels used in
support of national (or subnational) eﬀect factors reﬂect
population-weighted averages of outdoor PM2.5 concentrations
across rural and urbanized areas within each region. PM2.5
exposure levels used in support of city-speciﬁc eﬀect factors
reﬂect population-weighted averages of outdoor PM2.5
concentrations in each respective urban area. For comparing
cities or regions, the provided resolution in PM2.5 concen-
trations is suﬃcient, while higher resolutions would be
required for evaluating sources within a given city. Eﬀect
factors for ambient environments include exposures both
indoors and outdoors (i.e., without a signiﬁcation contribution
from indoor sources). We derive additional eﬀect factors
intended for application to situations, where indoor sources
constitute a substantial contribution to PM2.5 exposure. We use
archetypal levels to characterize environments with signiﬁcant
indoor emissions, for example, related to cook stoves, applying
an average indoor PM2.5 concentration of 250 μg/m
3 as
representative of such environments.43,44 Since indoor
emissions can vary among countries and households as a
function of sources and renewal rates, additional scenarios can
be evaluated following our general approach for deriving eﬀect
factors.
2.3.3. Mortality Data. Estimates of age- and disease-speciﬁc
mortality, M (deaths/year), for each of the ﬁve target health
outcomes included in the IER (i.e., IHD, stroke, COPD, lung
cancer, and ALRI) in each of the 419 regions of interest for the
year 2015 were obtained from the GBD Collaborative
Network.45 For IHD and stroke, we obtained speciﬁc data
for each of 12 age groups (25−29, ..., 75−79, and ≥80 years).
For COPD and lung cancer, we obtained data for adult
mortality (age ≥ 25 years). For ALRI, we used data on
mortality of infants and very young children (age ≤ 5 years).
Mortality data are available for countries or subnational regions
and are applied additionally to all cities in their respective
regions.
2.3.4. Attributable Risk Fraction and Deaths Attributable
to PM2.5 Exposure. Multiplying the attributable risk fraction,
ARF (dimensionless), by the current overall mortality, M
(death/year), in any given region provided us the mortality
(i.e., number of deaths) attributable to PM2.5 exposure, MPM2.5
(deaths/year), in that region, i.e., MPM2.5 = ARF × M. For the
case of ambient air pollution, in which the entire population is
exposed, the attributable risk fraction is a simple function of
the relative risk, i.e., ARF = (RR − 1)/RR.
2.3.5. Severity Factors. Estimates of disease- and region-
speciﬁc severity factors for mortality, SFYLL (YLL/death), and
for morbidity and mortality combined, SFDALY (DALY/death),
for the year 2015 were obtained from the GBD Collaborative
Network.45 Severity varies up to a factor of 5, mainly due to
regional diﬀerences in life expectancy.46 In the calculation of
YLL, the GBD has relied since 2015 on a reference life table
constructed using the lowest age-speciﬁc mortality rates seen in
2013 in any population larger than 5 million capita.46
2.3.6. Exposed Population and Breathing Rate. To
compare emission scenarios we relate emission mass to
exposure in order to apply eﬀect factors using available intake
fraction methods as well as population and breathing rate
data.39 We obtained population counts across all ages, Npop
(capita), for 3448 cities41 and for 419 regions of interest for
the year 2015.45 Population counts were summed to city and
region deﬁnitions. To assess intake, we used a nominal
population-average breathing rate of BR = 11.68 m3/person/
d,39,44 accounting for time fractions spent and activity indoors
and outdoors,44,47 and the equilibrium fraction of ambient
particles penetrating indoors.39 Due to missing global
spatialized data, we assumed an equal distribution of time
Environmental Science & Technology Article
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spent indoors/outdoors across cities and regions. This
approach leads to a value lower than the breathing rates
typically used in the intake fraction literature. However, to
facilitate comparison with previous estimates, our eﬀect factors
can easily be rescaled. When combining eﬀect factors with
intake fractions, which also include information on time spent
indoors/outdoors and on breathing rates, the same values for
these aspects should be used in both and ﬁnally cancel out.
2.4. Approaches for Deriving the Eﬀect Factor Slope.
As eﬀect factors reﬂect health impacts attributable to a unit
change in PM2.5 intake, they are obtained as the slope of the
relationship between mortality and mass of PM2.5 inhaled.
When studying the environmental performance of product or
service systems, diﬀerent slopes are relevant for addressing
diﬀerent perspectives. Consequential studies assess environ-
mental impacts expected in consequence of choosing one
studied system over another. This perspective requires
“marginal” eﬀect factor slopes. In contrast, attributional studies
assess environmental impacts along one life cycle of a given
system and require using “average” eﬀect factor slopes. For a
linear exposure−response function, marginal and average
slopes are identical. However, for nonlinear functions, such
as GBD’s IER, marginal and average slopes diﬀer. Diﬀerent
eﬀect factors are therefore needed for consequential and
attributional studies. Hence, we provide marginal eﬀect factors
EFmarginal at a given region or city exposure working point (C,
μg/m3) and average eﬀect factors EFaverage between a given
region or city exposure working point (C, μg/m3) and the
theoretical minimum risk exposure level (C0, μg/m
3). Both
types of eﬀect factors are calculated as a function of the
diﬀerence in mortality attributable to PM2.5 exposure, MPM2.5
(deaths/year), divided by the diﬀerence in intake, I (kg/year)
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∑ + Δ − × ×
Δ × × ×
×
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Table 1. Global and (Sub-)continental Eﬀect Factor (DALY/kg PM2.5 inhaled) Mean Values and Lower and Upper 95%
Conﬁdence Interval Limits (values in parentheses)
marginal slope average slope
region regions cities regions cities
global average 44 (17−127) 54 (35−124) 115 (49−355) 137 (55−1034)
continental regions
North America 115 (91−141) 103 (70−173) 302 (238−384) 259 (167−431)
Latin America 44 (18−80) 42 (12−107) 116 (45−229) 111 (31−283)
Europe 74 (23−141) 72 (22−149) 217 (63−465) 190 (53−437)
Africa and Middle East 43 (4−106) 31 (3−81) 92 (13−195) 77 (12−190)
Central Asia 49 (17−129) 60 (15−236) 138 (54−395) 201 (49−788)
Southeast Asia 33 (21−77) 32 (13−65) 92 (58−207) 87 (48−168)
Northern regions 123 (84−165) 187 (67−475) 366 (213−510) 584 (163−1754)
Oceania 178 (116−297) 112 (77−195) 638 (301−1511) 332 (192−762)
subcontinental regions
Central Asia 49 (17−127) 66 (15−270) 136 (54−388) 188 (49−818)
Indochina 48 (29−79) 41 (25−76) 127 (78−218) 107 (64−187)
Northern Australia 177 (115−293) 110 (79−156) 709 (297−1418) 312 (202−527)
Southern Australia and New Zealand 176 (115−293) 112 (75−197) 678 (290−1361) 349 (191−791)
Southern Africa 56 (27−94) 38 (23−67) 114 (69−194) 92 (60−154)
North, West, East, and Central Africa 37 (3−133) 28 (3−97) 84 (14−222) 71 (12−184)
Argentina+ 48 (23−120) 43 (19−60) 133 (62−317) 112 (48−165)
Brazil+ 60 (18−81) 56 (10−117) 164 (44−231) 148 (27−337)
Central America+ and Caribbean 30 (17−75) 25 (15−57) 78 (47−182) 69 (43−150)
United States and Southern Canada 115 (92−139) 100 (69−160) 301 (237−384) 255 (164−459)
Northern Europe and Northern Canada 125 (88−164) 194 (65−554) 374 (232−495) 595 (166−1681)
Europe 75 (24−141) 72 (20−148) 205 (62−450) 190 (48−433)
East Indies and Paciﬁc 85 (68−193) 62 (47−98) 219 (179−421) 173 (126−284)
India+ 28 (20−41) 29 (12−56) 80 (61−99) 82 (45−136)
Eastern China 26 (21−32) 27 (18−45) 72 (58−85) 73 (53−108)
Japan and Korean peninsula 57 (25−79) 44 (21−67) 142 (59−202) 107 (48−170)
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Equations 2a and 2b are derived from substituting the relative
risk in the relation of PM2.5-attributable mortality (see section
2.3.4) and PM2.5 exposure levels as described in section 2.1.
More speciﬁcally, RRi(Cj) is the relative risk obtained from eq
1 for disease i at the PM2.5 exposure level Cj in jth city (for
urban eﬀect factors) or in region j = r (for regional eﬀect
factors). Mi,r is the overall mortality in region r for disease i,
which contains the city of interest and all other cities and rural
areas in a given region. SFi,r is the corresponding region- and
disease-speciﬁc severity factor. Npop is the exposed population
and BR the individual breathing rate. Units are corrected via
factors fd to yr = 365 d/year and f kg to μg = 10
9 μg/kg. Ratio
(Mi,r)/(RRi(Cr) × Npop,r) is the regional background mortality
rate without the inﬂuence of PM2.5 exposure, calculated based
on the corresponding PM2.5 concentration of that region (i.e.,
Cr). If this ratio is multiplied by (RRi(Cr) − 1) in eq 2b, we get
the attributable mortality rate due to PM2.5 exposure. We
ﬁnally divide by inhaled PM2.5 mass per person (deaths/kg
inhaled) and multiply by the severity (DALY/death) to yield
the eﬀect factor (DALY/kg inhaled).
2.5. Implementation and Model Evaluation. We
implemented both the marginal and the average approaches
in Analytica Release 4.6 and in Microsoft Excel 2016 to derive
eﬀect factors for the considered 419 regions and 3448 cities.
Results from the two implementations were compared as a
quality control measure. All simulations were run using the full
set of 1000 equally likely realizations of relative risk model
parameters, and uncertainty ranges around eﬀect factors are
based on Monte Carlo simulations performed in Analytica.
To evaluate our eﬀect factor estimates we followed two
distinct approaches. First, we simpliﬁed the eﬀect factor model
in a regression, focusing on understanding the most relevant
aspects inﬂuencing variability in eﬀect factors. This yields
additional insight in aspects contributing to linking health
eﬀects to human intake and provides a simple tool for
practitioners to estimate eﬀect factors based on only knowing
the most relevant key inputs, namely, PM2.5 concentration,
mortality rates, and disease severity. Second, we compare our
eﬀect factors against recent spatialized factors and against
factors obtained following our proposed approach but using
another exposure−response relationship, namely, the recently
published Global Exposure Mortality Model (GEMM),48
synthesizing epidemiological evidence from cohorts in 16
countries. Unlike GBD’s IER, GEMM exclusively considers
studies on ambient PM2.5 exposure.
3. RESULTS
3.1. Eﬀect Factors for Total Mortality for Diﬀerent
Levels of Spatial Aggregation. We summarize our results
starting with the most general case in which the location of the
PM2.5 emission source is unknown (Table 1). In this case, our
central eﬀect factor estimates, EF (DALY/kg PM2.5 inhaled),
reﬂect the population-weighted (as surrogate for emission-
weighted) average of the marginal and average slopes for
morbidity and mortality attributable to PM2.5 exposure. When
there is no information about emission location, geographic
variability contributes signiﬁcantly to overall eﬀect factor
uncertainty. We characterize uncertainty by providing
conﬁdence intervals as well as expected values obtained from
the distributions of possible values.
Eﬀect factors based on the average slope of the exposure−
response function between the exposure working point and the
theoretical minimum risk exposure level tend to be ∼2.5 times
larger than eﬀect factors based on the marginal slope of the
exposure−response function evaluated at the exposure working
point. The mean marginal slope eﬀect factor averaged over the
419 considered regions is 44 DALY/kg PM2.5 inhaled, with
95% of region-speciﬁc values falling in the range from 17 to
127 DALY/kg PM2.5 inhaled. In contrast, the mean average
slope eﬀect factor averaged over the same 419 regions is 115
DALY/kg PM2.5 inhaled, with 95% of region-speciﬁc values
falling in the range from 49 to 355 DALY/kg PM2.5 inhaled.
Figure 1. Population-weighted distribution of average eﬀect factors due to PM2.5 exposure across cities (urbanized areas) and regions (including all
rural and urban areas within a region) per continent, with a comparison to the average eﬀect factor appropriate for scenarios with substantial
emissions from indoor sources. Boxes represent median and interquartile ranges, and whiskers represent ranges containing 95% of continent-
speciﬁc eﬀect factors. Continents are arranged from left-to-right in order of increasing mean eﬀect factors. Bars represent total population count
(capita) in each continental region and across cities per region.
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The mean marginal slope eﬀect factor averaged over the 3448
considered cities is 54 DALY/kg PM2.5 inhaled, with 95% of
city-speciﬁc values falling in the range from 35 to 124 DALY/
kg PM2.5 inhaled. In contrast, the mean average slope eﬀect
factor averaged over these same 3448 cities is 137 DALY/kg
PM2.5 inhaled, with 95% of region-speciﬁc values in the range
from 55 to >1000 DALY/kg PM2.5 inhaled. Typical city eﬀect
factors appear to be slightly (20−30%) larger than eﬀect
factors for regions with a wider variability across cities.
We next consider the case in which the location of PM2.5
emissions is relatively well known, where we can identify either
the city or the country (or subnational region) in which a
PM2.5 source of interest is located. Marginal and average slope
eﬀect factors for all 419 regions and 3448 cities are provided in
the Supporting Information (SI).
To provide factors for an intermediate level of spatial detail,
between unknown source location and rather precise source
speciﬁcation, we developed and summarize in Figure 1 the
average eﬀect factors for regions and cities, aggregated at the
level of continents. We estimated the continental weighted
median eﬀect factors by pooling the eﬀect factors for each
region or city using weights representing the fraction of the
population of the continent contributed by each region or city.
The continental median as well as the 2.5% and 97.5%
cumulative probability values come from the distribution (p1 ×
EF1 + p2 × EF2 + ... + pm × EFm), where p1, p2, ..., pm are
probabilistic weights (Bernoulli variables) taking the value 1
with probability p and 0 with probability 1 − p, and EF1, EF2,
..., EFm are probabilistic characterizations of the eﬀect factors
from each region or city within a given continent. Marginal and
average slope eﬀect factors for (sub)continents are provided in
Table 1.
Figure 1 shows average eﬀect factor estimates across regions
and urban areas per continent, respectively. In addition, Figure
1 shows the distribution of the average eﬀect factor for the
indoor environment archetype with substantial indoor
emission sources. For indoor environments, the eﬀect factor
based on the average slope between the exposure working
point and the theoretical minimum risk exposure level is
recommended, since indoor exposure reduction eﬀorts will
usually lead to a substantial (nonmarginal) change in indoor
PM2.5 concentrations.
49
Eﬀect factors tend to be higher for exposure levels in North
America, Oceania, and Northern Regions than for exposure
levels in Southeast Asia, Africa, and the Middle East, Latin
America, and Central Asia. Eﬀect factors in Europe tend to fall
between these. While there are diﬀerences in the typical eﬀect
factor by continent, the within-continent variation tends to be
Figure 2. Median eﬀect factor estimates for PM2.5 exposure in 3448 cities (top) and in 419 regions (bottom) with 95% conﬁdence intervals for
each city and region and with the distribution across all cities (top) and across all regions (bottom) indicated as right-side box plots. z-scores
indicate how many standard deviations city-/region-speciﬁc median eﬀect factors are from the respective mean across all considered cities/regions.
Median eﬀect factors based on GEMM48 are indicated as white dashes for comparison. Light-colored bars around median values indicate
conﬁdence interval ranges.
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larger than diﬀerences between values typical for various
continents.
Indoor eﬀect factors are lower than outdoor eﬀect factors
primarily due to the high working point exposures indoors
(due to cooking) that push the nonlinear model into a region
of lower slopes.
Figure 2 illustrates the variability and uncertainty in median
average eﬀect factor estimates for PM2.5 exposure in each of the
3448 considered cities. Of the 3618 cities initially considered,
170 were excluded from our analysis because their mean
ambient annual PM2.5 concentration was below the theoretical
minimum risk exposure level, yielding an eﬀect factor that is
either zero or almost inﬁnite. The vertical axis in Figure 2
reﬂects the range of city-speciﬁc eﬀect factor estimates, which
vary from less than 10 to 1900 DALY/kg PM2.5 inhaled. The
horizontal axis shows the z-score, indicating how many
standard deviations the median eﬀect factor for a speciﬁc
city is from the mean across cities, calculated as z-score = (X −
μ)/σ, with X being the median eﬀect factor for a given city, μ
the mean eﬀect factor across cities, and σ the standard
deviation. The fact that the 3448 city-speciﬁc median eﬀect
factor estimates lie, approximately, on a straight line suggests
that median average urban eﬀect factor estimates are
approximately log-normally distributed with a median of 133
DALY/kg PM2.5 inhaled and a geometric standard deviation of
1.95 (summarized in the box plot on the right side of Figure
2).
To illustrate the dependence of eﬀect factors on PM2.5
exposure concentration levels, we color coded the data shown
in Figure 2. Blue data points correspond to cities with PM2.5
concentrations between 5.8 and 15 μg/m3, yellow data points
correspond to cities with PM2.5 concentrations between 15 and
25 μg/m3, and red data points correspond to cities with PM2.5
concentrations above 25 μg/m3. Finally, gray data points
indicate cities with mean PM2.5 concentrations at or below the
upper conﬁdence interval limit of the theoretical minimum risk
exposure level of 5.8 μg/m3. Increasing PM2.5 exposure
concentrations yield lower eﬀect factors for both cities and
regions. This reﬂects the inﬂuence of the underlying nonlinear
exposure−response model, suggesting modest reductions in
Figure 3. Distribution of average slope median eﬀect factors across cities per country ranked according to increasing country-speciﬁc average eﬀect
factors that include all rural and urban areas for 147 countries with at least one city with more than 100 000 inhabitants.
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health burden in highly polluted areas unless PM2.5 levels
markedly decline.36
Uncertainty in each of our eﬀect factor estimates is reﬂected
in the error bars shown for each city- and region-speciﬁc value.
Because the GBD’s IER model is highly nonlinear with a slope
that approaches inﬁnity as PM2.5 concentration levels approach
the theoretical minimum risk exposure levels (which are
themselves uncertain), eﬀect factors become increasingly
uncertain at levels of PM2.5 near this exposure level, usually
reaching magnitudes beyond 500 DALY/kg inhaled. For
comparison, eﬀect factors based on GEMM (see Figure 2)
generally deviate from results based on GBD’s IER within a
factor of 2 but also suggest a less extreme trend at both ends of
the PM2.5 concentration range. In fact, very high eﬀect factors
are rather an artifact in the underlying exposure−response
driven by studies on active smokers rather than ambient PM2.5
exposure, while very low eﬀect factors are an artifact for forcing
the curve to meet the minimum risk exposure level.
To relate eﬀect factors in cities to those of their respective
regions, we plot in Figure 3 the relationship of average eﬀect
factors between the various cities in each of the 175 considered
countries (subnational regions were aggregated to national
estimates) and the average slope eﬀect factor for the respective
country (considering all rural and urban areas in that country).
Only 147 out of the 175 considered countries contain cities
with more than 100 000 inhabitants. For these countries, the
number of cities ranges from a single city in, e.g., Iceland to
337 cities in India and 827 cities in China. In several countries,
Figure 4. Eﬀect factors estimated in the present study derived from the GBD IER (Integrated Exposure-Response) model36 for 419 regions
compared against (a) their respective PM2.5 exposure levels, (b) our simpliﬁed regression model, (c) eﬀect factors provided by van Zelm et al.
(2016),24 and (d) eﬀect factors derived from the Global Exposure Mortality Model (GEMM).48 Regression coeﬃcients in (b) are for eﬀect factors
(EF, DALY/kg inhaled) in regions (including urban and rural areas). Madult (deaths/person-year), SF (DALY/death), and C (μg/m3), respectively,
denote total adult mortality (considering IHD, stroke, COPD, and lung cancer, for age groups ≥ 25 years), average severity factor over all age
groups for the same diseases, and annual average PM2.5 exposure concentration per region. Plotted eﬀect factor ranges are restricted to 800 DALY/
kg inhaled.
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city-speciﬁc eﬀect factors vary considerably, indicating that it is
important to distinguish urban and rural factors and individual
cities whenever related emission information is available. City-
speciﬁc eﬀect factors being higher than the related country
averages across cities indicates that the overall country average
is driven by (usually large) cities with higher PM2.5 levels and
related lower eﬀect factors.
3.2. Determinants of Eﬀect Factors: Simpliﬁed
Regression. In an eﬀort to understand the determinants of
eﬀect factors related to PM2.5 exposure, we analyzed our results
statistically. We found that for urban areas, marginal and
average eﬀect factors are well approximated with simple
regression models of the following form:
= + × ×
−
EF
k k M SF
C k
( )1 2
adult
3 (3)
where Madult is the total adult mortality rate (deaths/person-
year) from the four related diseases considered by GBD’s IER
model for age groups ≥ 25 years (derived from the ratio of the
sum over age group speciﬁc deaths/year and population
count), SF is the average severity factor (over all age groups)
for the same four diseases, C is the annual average ambient
PM2.5 exposure concentration (μg/m
3) in the area of interest,
and k1, k2, and k3 are ﬁtting parameters.
First, we compared eﬀect factors with their respective PM2.5
exposure levels (Figure 4a). Using 1/C as the regression model
explained 18% of the variance when taking average slope eﬀect
factors across our 419 considered regions. In a second model
for the same data set, we estimated eﬀect factors from 1/(C −
k3), which explained 22% of the eﬀect factors variance.
Including mortality into the regression of the form (k2 ×
Madult)/(C − k3) already explained 77% of our eﬀect factor
variance. Finally, we introduced severity factors into the model,
which then takes the form as in eq 3, and explains 94% of the
variance of average slope eﬀect factors across regions as shown
in Figure 4b.
For the 419 regions in our analysis, optimal values of model
parameters for marginal slope eﬀect factors, EFregion
marginal, are k1 =
8 deaths/person-year, k2 = 15 028, and k3 = 0 μg/m
3, yielding
R2 = 0.95. For average slope eﬀect factors, EFregion
average, in the 419
regions, the optimal parameter values are k1 = 0 deaths/
person-year, k2 = 28 100, and k3 = 3.9 μg/m
3, yielding R2 =
0.94. It can be shown that for an average slope eﬀect factor, the
constant k2 is an estimate of the average adjusted relative risk
value of × [ − ] ×μ ( )RR C RR C BR10 ( ( ) 1)/ ( ) / 3659 gkg dyear .
With the value of the nominal per-capita daily breathing rate
of 11.68 m3/person/d used in our analysis, an estimate of k2 of
28 100 is consistent with an average attributable risk fraction of
0.12, corresponding to a relative risk of RR = 1.136. The
constant k3 of 3.9 μg/m
3 is an estimate of the theoretical
minimum risk exposure level of PM2.5.
For the 3448 cities considered in our analysis, the optimal
values of model parameters for marginal slope eﬀect factors,
EFcity
marginal, are k1 = 11 deaths/person-year, k2 = 13 800, and k3 =
0.3 μg/m3, giving R2 = 0.96. For average slope eﬀect factors in
cities, EFcity
average, the optimal parameter values are k1 = 11
deaths/person-year; k2 = 36 311, and k3 = 1.7 μg/m
3, giving R2
= 0.89. It can be shown that for a marginal slope eﬀect factor
the constant k2 is again an estimate of the average adjusted
relative risk value, which is consistent with an average
attributable risk fraction of 0.154, corresponding to a relative
risk of RR = 1.182. The constant k3 of 1.7 μg/m
3 is again an
estimate of the theoretical minimum risk exposure level of
PM2.5. Overall, our simpliﬁed regression model predicts eﬀect
factors very well, using only information on PM2.5 exposure
concentration, total adult mortality, and severity for any given
region or city, which is readily available from the GBD study
and global PM2.5 monitoring data.
4. DISCUSSION
4.1. Applicability of Our Eﬀect Factors. We proposed a
consistent set of global eﬀect factors that can be combined
with human intake fractions39 in support of comparative
assessments that are relevant to a broad range of emission and
related exposure situations, applicable to a diverse number of
populations, cities, and countries, and applicable for diﬀerent
levels of spatial aggregation. While we can currently not
diﬀerentiate between anthropogenic and nonanthropogenic
PM2.5 sources (i.e., our approach is equally applicable to both),
future eﬀorts should focus on providing eﬀect factors that are
diﬀerentiated by source type. We found that estimating PM2.5
eﬀect factors requires information for ﬁve underlying aspects,
namely, (i) shape and parameters of the epidemiology-based
exposure−response function, (ii) levels of PM2.5 exposure in
the considered population, (iii) mortality rates for PM2.5
exposure-related diseases, (iv) severity factors reﬂecting loss
of life expectancy and duration and severity of disease-related
disability preceding death, and (v) amount of air inhaled by the
exposed population. Of these, the most critical and uncertain
information is that related to the exposure−response function.
Comparing 4.2 with 8.9 million deaths globally estimated for
2015 using, respectively, GBD’s IER model36 and the
GEMM48 (using all cohorts) indicates uncertainty of the
exposure−response of at least a factor of 2. This is dominating
as compared to other contributors to uncertainty (breathing
rates, exposure concentrations, and indoor/outdoor time
patterns), which generally vary much less than a factor of
2.41,44 In the mid-1990s, evidence about the exposure−
response relating chronic exposure to mortality was limited
to the results from two cohort studiesthe Six Cities study2
and the ACS study3these gave central eﬀect estimates, which
diﬀered by a factor of 3. More than 20 years later, results from
a dozen relatively large cohort studies and an equal number of
smaller cohorts contribute to our understanding of this issue.
A number of eﬀect factor estimates for PM2.5 exposure has
been proposed. All estimates have relied, almost exclusively, on
evidence from one cohort, i.e., the ACS study3 (and its
extensions and reanalyses). Although it is one of the largest
and best-studied cohorts and used by regulatory authorities in
the United States and Europe, we identiﬁed concerns about the
ACS study. In particular, because of its use of ambient air
exposures and health data for the United States, it may be
unable to provide the best possible synthesis of evidence on
mortality eﬀects of chronic exposure to PM2.5 for use in the
development of globally applicable eﬀect factors.
The IER model provides an alternative synthesis,32 has been
used to support estimates of the Global Burden of Disease
since 2010, and has provided the basis for a number of
independent studies of the mortality impacts of chronic
exposure to ambient PM2.5.
1,29,30,33−36 GBD’s IER model relies
on evidence from all major cohort studies of mortality related
to chronic exposure to PM2.5 and supplements this with
information from studies of mortality impacts from exposure to
smoke in households, which rely on dirty fuels for indoor
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cooking and heating, and from studies of exposure to both
active and passive cigarette smoke. Using this model in our
approach to develop global eﬀect factors constitutes a more
consistent picture than relying on evidence from a single
region, thereby accounting for spatial variability in important
underlying aspects including PM2.5 exposure levels, mortality,
and disease severity.
4.2. Evaluation against Other Factors and Models.We
explored the implications of using the synthesis provided by
GBD’s IER model for deriving eﬀect factors and observed the
following. First, our central estimates of global population-
weighted marginal region and city eﬀect factors are 44 and 54
DALY/kg PM2.5 inhaled, respectively. The variability in
marginal slope eﬀect factors across regions is substantial. If
the location of a PM2.5 emissions source is unknown, the
marginal slope eﬀect factor could be between 17 and 127 (with
95% conﬁdence). Similar variability is found for emissions
across cities. Second, our central estimates of the global
population-weighted average slope region and city eﬀect
factors are 2−3 times as large as the corresponding marginal
slope eﬀect factors. The variability in average slope eﬀect
factors is also substantial. If the location of an emissions source
is unknown, the average slope eﬀect factor could be between
49 and 355 (with 95% conﬁdence). Similar variability is again
found across cities. We recommend applying the average eﬀect
factors rather than the marginal eﬀect factors in cases where
substantial variations in background PM2.5 exposure concen-
trations are expected over the lifetime of a considered system
under analysis. This is, for example, the case in China, where a
substantial reduction in concentrations has been observed in
recent years and are expected in the coming decade, or for
analyzing indoor PM mitigation scenarios, for which cooking
alternatives can strongly reduce PM exposure levels. Third,
although eﬀect factors tend to be somewhat higher for some
continents (North America, Oceania, Northern Regions) than
for others (Southeast Asia, Central Asia, Latin America, Africa,
and the Middle East), most of the variability in eﬀect factors is
within continent and is determined largely by variation in the
average annual mean PM2.5 exposure concentrations from
place to place. This occurs because of the nonlinearity of the
IER exposure−response, which exhibits low slopes at high
PM2.5 exposure concentrations and increasingly large slopes as
PM2.5 exposure concentrations decrease toward the theoretical
minimum risk exposure level of PM2.5. Fourth, our estimates of
the population-weighted marginal and average slope eﬀect
factors for Europe are, respectively, ∼70 and ∼150 DALY/kg
PM2.5 inhaled and for North America, respectively, ∼110 and
∼290 DALY/kg PM2.5 inhaled. Diﬀerences between Europe
and the United States are mainly driven by lower PM2.5 levels
in the United States (leading to higher exposure−response
slopes), and our estimates are only slightly larger than previous
estimates of 58 YLL per kg PM2.5 inhaled (Europe)
22 and 78
DALY per kg PM2.5 inhaled (United States).
23 Fifth, similar to
recent studies,24,25 we provide estimates of eﬀect factors
appropriate for various countries and regions worldwide. Our
estimates of population-weighted marginal slope eﬀect factors
are both variable and uncertain, with typical values varying
from 27 DALY/kg PM2.5 inhaled (95% conﬁdence interval,
17−120) in Central Asia to 168 DALY/kg PM2.5 inhaled (95%
conﬁdence interval, 78−306) in Northern Regions. Previous
estimates are also variable and uncertain, varying from 87
YLL/kg PM2.5 inhaled in Thailand to 857 YLL/kg PM2.5
inhaled in Kazakhstan.24 However, as Figure 4c shows, the
diﬀerent sets of estimates present quite distinct pictures of
both the patterns and sources of variability and the nature and
extent of uncertainty in eﬀect factor estimates. These
diﬀerences are primarily due to the nonlinearity in GBD’s
IER model being the major source of variability in our
estimates, a feature not present in earlier estimates.24,25
In conducting this analysis we are not proposing that eﬀect
factors based on GBD’s IER model are more reliable than
estimates based on other syntheses of the epidemiological
evidence for mortality eﬀects of PM2.5. Instead, the goal of our
analysis is to illustrate the importance of the approach used to
synthesize exposure−response evidence for compiling a
globally consistent set of eﬀect factors that allow for evaluating
emission and emission reduction situations at diﬀerent spatial
levels. We note that uncertainty about how to synthesize
epidemiological evidence is arguably the largest, often
unacknowledged source of uncertainty in PM2.5 eﬀect factor
estimates. To evaluate this aspect, we ﬁnally developed eﬀect
factors following our general approach but using the recently
published Global Exposure Mortality Model (GEMM)48 and
compared results against our factors based on GBD’s IER
model (see Figure 2). Comparing both sets of eﬀect factors for
the 419 considered regions we ﬁnd that GEMM-based factors
overall agree well with IER-based factors (Figure 4d); however,
there are some deviations especially at very high and very low
PM2.5 exposure levels, where the GEMM is less nonlinear than
the IER model. This suggests that the relative risk estimates
underlying our analysis could be potentially limited at both
extremes of the considered PM2.5 range to yield eﬀect factors
that are better aligned with GEMM and less inﬂuenced by
artifacts related to the IER shape. An advantage of using
GEMM as the underlying exposure−response model could be
that each included cohort can be ﬁtted separately for a given
region. However, additional research is required to select, for
example, the appropriate cohorts in GEMM for regions where
no epidemiological evidence is currently available.
On the basis of the current state-of-the-science synthesis
used by the GBD study,36 our eﬀect factor estimates can be
consistently coupled with the indoor and outdoor region and
city-speciﬁc intake fractions39 for use in LCIA, comparative
risk and health impact assessments, and emission reduction
policy analyses. Our continental, country- and region-level, and
city-speciﬁc eﬀect factors thereby capture important variability
in mortality from exposure to PM2.5, which is not possible with
currently available spatialized models. As science advances and
new syntheses of the epidemiological evidence on mortality
attributable to PM2.5 exposure becomes available, our approach
can easily accommodate this new information to produce
updated global eﬀect factors for exposure to PM2.5.
4.3. Recommendations for Policy and Practitioners.
Eﬀect factors for exposure to PM2.5 combined with intake
fractions39 provide important insight when evaluating diﬀerent
emission and emission reduction situations. Eﬀect factors vary
considerably across cities and regions (Figures 1 and 3), with
lower eﬀect factors in areas with higher PM2.5 exposure and
highest eﬀect factors in areas with PM2.5 exposure close to the
minimum risk exposure level (Figures 2 and 4a). Current
spatial models are unable to capture the most important
related variabilities in eﬀect factors (see Figure 4c). Our
consistent set of global eﬀect factors addresses this spatial
variability by covering diﬀerent spatial scales through para-
metrized cities and countries (or subnational regions),
continents, and global averages that can be applied as a
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function of information available about emission location. We
recommend using as underlying exposure−response model
GBD’s IER covering a wide range of PM2.5 exposure
concentrations based on a large set of epidemiological studies
from diﬀerent regions36 while further exploring other models,
such as GEMM.48 GEMM is generally in good agreement with
the IER but also exhibits important diﬀerences, such as a more
linear behavior at high PM2.5 exposures (see Figure 4d).
However, important questions still need to be addressed before
GEMM can be applied in a global context, for example,
selection of appropriate cohorts in areas without available
epidemiological evidence. We generally recommend applying
eﬀect factors derived from an average slope, where substantial
variations in background PM2.5 exposure are expected over the
lifetime of an assessed product system or as consequence of
emission or exposure reduction eﬀorts. Finally, when only
limited information is available regarding PM2.5 exposure,
mortality, and disease severity, we recommend applying our
simpliﬁed regression model (eq 3, Figure 4b) with diﬀerent
ﬁtting coeﬃcients for regions, cities, and marginal versus
average slopes. Further research should focus on providing
globally spatialized data on time spent indoors/outdoors,
breathing rates, additional health outcomes associated with
PM2.5 exposure, epidemiological evidence in regions currently
not covered, and eﬀect factors diﬀerentiated by source type.
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